Page last updated: 2024-11-12
1-azafagomine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
1-azafagomine: inhibits processing glycosidase; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10329422 |
| SCHEMBL ID | 12232221 |
| MeSH ID | M0371664 |
Synonyms (9)
| Synonym |
|---|
| azafagomine |
| 2J7H |
| SCHEMBL12232221 |
| (3r,4r,5r)-3-(hydroxymethyl)hexahydropyridazine-4,5-diol |
| 193540-72-6 |
| (3r,4r,5r)-3-(hydroxymethyl)diazinane-4,5-diol |
| 1-azafagomine |
| Q27458140 |
| 4,5-pyridazinediol,hexahydro-3-(hydroxymethyl)-,(3r,4r,5r)-rel-(9ci) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||